Abstract
We report a case of blindness, secondary to hormone-refractory prostate cancer, occurring 7 years after the diagnosis of metastatic prostate cancer and 3.5 years after the clinical onset of the hormone-refractory state. Prolonged suppression of the disease with chemotherapy may have contributed to the unusual clinical findings. We discuss the role of supportive care in the management of prostate cancer.
This is a preview of subscription content, log in via an institution to check access.
References
Chung TS, Thannikkary C (1986) Carcinoma of the prostate with brain metastasis. J Surg Oncol 33:103–105
Collste LG (1990) Second line treatment of hormone refractory prostatic cancer patient. Prog Clin Biol Res 357:39–44
Greenberg HS, Deck MDF, Vikram G, et al (1981) Metastases to the base of the skull: clinical findings in 43 patients. Neurology 31:530–537
Kistler M, Pribram H (1975) Metastatic disease of the sella tucica. Am J Roentgenol Radium Ther Nucl Med 123:13–21
Lynes WL, Bostwick DG, Freiha FS, Stamey TA (1986) Parenchumal brain metastases from adenocarcinoma of prostate. Urology 28:280–287
Osborne CK, Blumenstein B, Crawford ED, Coltman CA, Smith AY, Lambuth BW, Chapman RA (1990) Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group Study. J Clin Oncol 8:1675–1682
Ransom DT, Dinapoli RP, Richardson RL (1990) Cranial nerve lesions due to base of the skull metastases in prostate carcinoma. Cancer 65:586–589
Sarma DP, Godeau L (1983) Brain metastasis from prostatic cancer. J Surg Oncol 2:173–174
Scher HI, Culey T, Geller N, Engstrom C, Dershaw DD, Shoiw-Yun L, Fitzpatrick K, Nisselbaum J, Schwartz M, Bezirdjian L, Eisenberger M (1990) Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable homone refractory disease. J Clin Oncol 8:1830–1838
Seymore CH, Peeples WJ (1988) Cranial nerve involvement with carcinoma of the prostate. Urology 31:211–213
Svare A, Fossa SD, Herier MS (1988) Cranial nerve dysfunction in metastatic cancer of the prostate. Br Urol 61:441–444
Taylor HG, Lefkowitz M, Skoog SJ, Miles BJ, McLeod DG, Coggin JT (1984) Intracranial metastases in prostate cancer. Cancer 53:2728–2730
Vogelzang NJ (1992) Genitourinary cancer. In: Perry M (ed) Chemotherapy source book. Wiley/Liss, New York, pp 1008–1038
Zappia RJ, Morton ES, Gay AJ (1972) Prostatic carcinoma metastatic to optic nerve and choroid. Arch Ophthalmol 87:642–645
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vogelzang, N.J., Olson, D. & Chodak, G.W. Blindness secondary to prostate cancer. Support Care Cancer 1, 156–158 (1993). https://doi.org/10.1007/BF00366063
Issue Date:
DOI: https://doi.org/10.1007/BF00366063